Overview

To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The study was designed to determine if Androxal® would affect sperm parameters (count, concentration, volume) in men with secondary hypogonadism who have been previously treated with topical testosterone.
Phase:
Phase 2
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Clomiphene
Enclomiphene
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
Zuclomiphene